Walleye Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Walleye Capital's MDGL Position: Q3 2026 in Review
Walleye Capital opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 366 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #4870 among its holdings. This is a return to the name: Walleye Capital previously reported a position in MDGL as recently as Q1 2026.
Walleye Capital first reported a position in MDGL in Q4 2019 and has held it in 7 quarters since. The position peaked at $6.92M in Q1 2026. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Walleye Capital held 366 shares of Madrigal Pharmaceuticals worth $184K as of Q3 2026.
- Madrigal Pharmaceuticals was a new Walleye Capital position in Q3 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4870 holding.
- Walleye Capital first reported a position in Madrigal Pharmaceuticals in Q4 2019 and has held it in 7 quarters since.
- Walleye Capital's Madrigal Pharmaceuticals position peaked at $6.92M in Q1 2026.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.